血管紧张素-话题@MedSci

#血管紧张素#

103篇内容 | 2958人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1589337, encodeId=5103158933ea4, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=J Endod：血管紧张素II调节根尖牙乳头干细胞增殖和功能, objectType=article, longId=193323, objectId=8fda193323dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fda193323dd, replyNumber=0, likeNumber=72, createdTime=2020-05-03, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fda193323dd, moduleTitle=J Endod：血管紧张素II调节根尖牙乳头干细胞增殖和功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fda193323dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589336, encodeId=286b1589336df, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=GUT：肾素-血管紧张素系统的失衡可能导致IBD的肠道炎症和纤维化 , objectType=article, longId=191617, objectId=e63119161e95, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e63119161e95, replyNumber=0, likeNumber=65, createdTime=2020-04-08, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e63119161e95, moduleTitle=GUT：肾素-血管紧张素系统的失衡可能导致IBD的肠道炎症和纤维化 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e63119161e95)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589335, encodeId=8c5f1589335d0, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=Clin Chem：平衡血管紧张素II在原发性醛固酮增多症诊断中的应用, objectType=article, longId=191513, objectId=ff941915133d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff941915133d, replyNumber=0, likeNumber=94, createdTime=2020-04-07, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff941915133d, moduleTitle=Clin Chem：平衡血管紧张素II在原发性醛固酮增多症诊断中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff941915133d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589334, encodeId=7a06158933466, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=Eur Respir J：肺动脉高压患者血管紧张素转换酶2和血管紧张素(1-7)轴变化, objectType=article, longId=191348, objectId=857d191348e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=857d191348e4, replyNumber=0, likeNumber=63, createdTime=2020-04-05, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=857d191348e4, moduleTitle=Eur Respir J：肺动脉高压患者血管紧张素转换酶2和血管紧张素(1-7)轴变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=857d191348e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589333, encodeId=79661589333be, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=重组人血管紧张素转化酶2治疗COVID-19的II期临床试验：即将开始, objectType=article, longId=191296, objectId=4009191296a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4009191296a0, replyNumber=0, likeNumber=52, createdTime=2020-04-04, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4009191296a0, moduleTitle=重组人血管紧张素转化酶2治疗COVID-19的II期临床试验：即将开始, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4009191296a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589332, encodeId=ea12158933202, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=EMA建议新冠病毒COVID-19感染的高血压患者，继续服用血管紧张素转化酶抑制剂, objectType=article, longId=191243, objectId=8009191243cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8009191243cd, replyNumber=0, likeNumber=40, createdTime=2020-04-03, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8009191243cd, moduleTitle=EMA建议新冠病毒COVID-19感染的高血压患者，继续服用血管紧张素转化酶抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8009191243cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589331, encodeId=5aa115893316a, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=ACE抑制剂和血管紧张素受体阻滞剂（ARBs）可能增加罹患COVID-19的风险, objectType=article, longId=190727, objectId=788c190e27af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=788c190e27af, replyNumber=0, likeNumber=75, createdTime=2020-03-26, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=788c190e27af, moduleTitle=ACE抑制剂和血管紧张素受体阻滞剂（ARBs）可能增加罹患COVID-19的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=788c190e27af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589330, encodeId=1a3c158933053, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=Clinica Chimica Acta：血管紧张素转换酶和几丁三苷酶联合应用可提高结节病的实验室诊断？, objectType=article, longId=189125, objectId=70641891250b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70641891250b, replyNumber=0, likeNumber=57, createdTime=2020-03-03, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70641891250b, moduleTitle=Clinica Chimica Acta：血管紧张素转换酶和几丁三苷酶联合应用可提高结节病的实验室诊断？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70641891250b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589329, encodeId=020e158932979, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=JAMA：减少血管紧张素暴露对老年重症患者血管扩张性低血压90天死亡率的影响, objectType=article, longId=188945, objectId=2b2d18894526, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b2d18894526, replyNumber=0, likeNumber=64, createdTime=2020-02-29, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b2d18894526, moduleTitle=JAMA：减少血管紧张素暴露对老年重症患者血管扩张性低血压90天死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b2d18894526)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589328, encodeId=abcc1589328ed, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=Eur Heart J：肾素-血管紧张素抑制剂对接受TAVR严重主动脉瓣狭窄患者临床结局的影响, objectType=article, longId=183545, objectId=66af18354590, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66af18354590, replyNumber=0, likeNumber=91, createdTime=2019-11-26, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66af18354590, moduleTitle=Eur Heart J：肾素-血管紧张素抑制剂对接受TAVR严重主动脉瓣狭窄患者临床结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66af18354590)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589327, encodeId=739e158932eb9, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=欧盟批准血管紧张素II（Giapreza）治疗难治性低血压, objectType=article, longId=178529, objectId=ba971e852912, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba971e852912, replyNumber=0, likeNumber=98, createdTime=2019-09-03, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba971e852912, moduleTitle=欧盟批准血管紧张素II（Giapreza）治疗难治性低血压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba971e852912)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589326, encodeId=ba35158932654, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=GUT：肾素-血管紧张素系统(RAS)与炎症性肠病, objectType=article, longId=178074, objectId=d5cc1e80743c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5cc1e80743c, replyNumber=0, likeNumber=84, createdTime=2019-08-23, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5cc1e80743c, moduleTitle=GUT：肾素-血管紧张素系统(RAS)与炎症性肠病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5cc1e80743c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589325, encodeId=386d158932527, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=JACC：肾素-血管紧张素抑制剂对TAVR术后患者有心血管保护作用, objectType=article, longId=176942, objectId=44c91e6942b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44c91e6942b2, replyNumber=0, likeNumber=59, createdTime=2019-08-07, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44c91e6942b2, moduleTitle=JACC：肾素-血管紧张素抑制剂对TAVR术后患者有心血管保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44c91e6942b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589324, encodeId=0f4215893241d, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=Dig Dis Sci：阻断血管紧张素II信号通路对炎症性肠病患者临床结局的影响, objectType=article, longId=174952, objectId=d1991e4952c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1991e4952c0, replyNumber=0, likeNumber=75, createdTime=2019-07-08, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1991e4952c0, moduleTitle=Dig Dis Sci：阻断血管紧张素II信号通路对炎症性肠病患者临床结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1991e4952c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589323, encodeId=095d1589323b7, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=JAHA：血管紧张素受体蛋白酶抑制剂在改善心脏重塑方面优于ACEI, objectType=article, longId=174344, objectId=86131e43445b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86131e43445b, replyNumber=0, likeNumber=78, createdTime=2019-06-29, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86131e43445b, moduleTitle=JAHA：血管紧张素受体蛋白酶抑制剂在改善心脏重塑方面优于ACEI, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86131e43445b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589322, encodeId=46d7158932217, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=AGING CELL：血管紧张素受体通过抗氧化因子保护内皮细胞衰老, objectType=article, longId=160417, objectId=4fee16041e21, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fee16041e21, replyNumber=0, likeNumber=100, createdTime=2019-02-20, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fee16041e21, moduleTitle=AGING CELL：血管紧张素受体通过抗氧化因子保护内皮细胞衰老, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fee16041e21)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589321, encodeId=753215893218f, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=NEJM：血管紧张素-脑啡肽酶抑制剂对急性失代偿性心力衰竭患者疗效分析, objectType=article, longId=159632, objectId=b5c315963248, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5c315963248, replyNumber=0, likeNumber=58, createdTime=2019-02-09, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5c315963248, moduleTitle=NEJM：血管紧张素-脑啡肽酶抑制剂对急性失代偿性心力衰竭患者疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5c315963248)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589320, encodeId=8313158932068, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=J INTERN MED：血管紧张素II受体阻断剂对血管紧张素转换酶抑制剂相关的血管神经性水肿患者是安全的, objectType=article, longId=156150, objectId=0066156150be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0066156150be, replyNumber=0, likeNumber=0, createdTime=2018-12-20, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0066156150be, moduleTitle=J INTERN MED：血管紧张素II受体阻断剂对血管紧张素转换酶抑制剂相关的血管神经性水肿患者是安全的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0066156150be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589319, encodeId=7e251589319a2, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=JASN：肾素-血管紧张素系统（RAS）抑制对心肾结局的长期影响, objectType=article, longId=153482, objectId=6d9015348215, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d9015348215, replyNumber=0, likeNumber=64, createdTime=2018-11-15, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d9015348215, moduleTitle=JASN：肾素-血管紧张素系统（RAS）抑制对心肾结局的长期影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d9015348215)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589318, encodeId=72c415893182f, content=<a href='/topic/show?id=fb0389e4373' target=_blank style='color:#2F92EE;'>#血管紧张素#</a>, objectTitle=J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系, objectType=article, longId=152882, objectId=97e515288294, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97e515288294, replyNumber=0, likeNumber=100, createdTime=2018-11-08, rootId=0, userName=xiongliangxl, userId=5ce517702394, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97e515288294, moduleTitle=J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97e515288294)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

血管紧张素

2020-05-29

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

J Endod：血管紧张素II调节根尖牙乳头干细胞增殖和功能

2020-05-03

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

GUT：肾素-血管紧张素系统的失衡可能导致IBD的肠道炎症和纤维化

2020-04-08

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

Clin Chem：平衡血管紧张素II在原发性醛固酮增多症诊断中的应用

2020-04-07

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

Eur Respir J：肺动脉高压患者血管紧张素转换酶2和血管紧张素(1-7)轴变化

2020-04-05

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

重组人血管紧张素转化酶2治疗COVID-19的II期临床试验：即将开始

2020-04-04

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

EMA建议新冠病毒COVID-19感染的高血压患者，继续服用血管紧张素转化酶抑制剂

2020-04-03

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

ACE抑制剂和血管紧张素受体阻滞剂（ARBs）可能增加罹患COVID-19的风险

2020-03-26

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

Clinica Chimica Acta：血管紧张素转换酶和几丁三苷酶联合应用可提高结节病的实验室诊断？

2020-03-03

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

JAMA：减少血管紧张素暴露对老年重症患者血管扩张性低血压90天死亡率的影响

2020-02-29

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

Eur Heart J：肾素-血管紧张素抑制剂对接受TAVR严重主动脉瓣狭窄患者临床结局的影响

2019-11-26

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

欧盟批准血管紧张素II（Giapreza）治疗难治性低血压

2019-09-03

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

GUT：肾素-血管紧张素系统(RAS)与炎症性肠病

2019-08-23

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

JACC：肾素-血管紧张素抑制剂对TAVR术后患者有心血管保护作用

2019-08-07

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

Dig Dis Sci：阻断血管紧张素II信号通路对炎症性肠病患者临床结局的影响

2019-07-08

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

JAHA：血管紧张素受体蛋白酶抑制剂在改善心脏重塑方面优于ACEI

2019-06-29

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

AGING CELL：血管紧张素受体通过抗氧化因子保护内皮细胞衰老

2019-02-20

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

NEJM：血管紧张素-脑啡肽酶抑制剂对急性失代偿性心力衰竭患者疗效分析

2019-02-09

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

J INTERN MED：血管紧张素II受体阻断剂对血管紧张素转换酶抑制剂相关的血管神经性水肿患者是安全的

2018-12-20

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

JASN：肾素-血管紧张素系统（RAS）抑制对心肾结局的长期影响

2018-11-15

xiongliangxl (审核中...)

前往app查看评论内容

#血管紧张素#

J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系

2018-11-08

科室
- - 订阅+
  - 更多科室
工具
服务